SHANDONG BOAN BIOTECH.H 1 (UJ9) — Net Asset Quality Index
SHANDONG BOAN BIOTECH.H 1 (UJ9) has a Net Asset Quality Index of 66.4% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €4.13 Billion minus total liabilities of €1.39 Billion yields net assets of €2.74 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check SHANDONG BOAN BIOTECH.H 1 liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
SHANDONG BOAN BIOTECH.H 1 Net Asset Quality Index Over Time (2021–2025)
This chart shows how SHANDONG BOAN BIOTECH.H 1's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 66.4%, representing net assets of €2.74 Billion against total assets of €4.13 Billion EUR. See UJ9 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for SHANDONG BOAN BIOTECH.H 1 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for SHANDONG BOAN BIOTECH.H 1 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see SHANDONG BOAN BIOTECH.H 1 stock valuation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 66.4% | €2.74 Billion | €4.13 Billion | €1.39 Billion | ▲ +8.8 pp |
| 2024 | 57.7% | €1.64 Billion | €2.85 Billion | €1.21 Billion | ▲ +0.9 pp |
| 2023 | 56.8% | €1.32 Billion | €2.32 Billion | €1.00 Billion | ▼ -7.6 pp |
| 2022 | 64.4% | €1.42 Billion | €2.20 Billion | €784.18 Million | ▼ -9.3 pp |
| 2021 | 73.7% | €1.55 Billion | €2.11 Billion | €554.92 Million | — |